Moderna, Inc. (MRNA)
212.89
-23.61
(-9.98%)
USD |
NASDAQ |
Oct 16, 12:00
Moderna SG&A Expense (TTM) : 965.00M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 965.00M |
| March 31, 2026 | 979.00M |
| December 31, 2025 | 1.018B |
| September 30, 2025 | 1.061B |
| June 30, 2025 | 1.074B |
| March 31, 2025 | 1.112B |
| December 31, 2024 | 1.174B |
| September 30, 2024 | 1.293B |
| June 30, 2024 | 1.454B |
| March 31, 2024 | 1.518B |
| December 31, 2023 | 1.549B |
| September 30, 2023 | 1.454B |
| June 30, 2023 | 1.29B |
| March 31, 2023 | 1.169B |
| December 31, 2022 | 1.132B |
| September 30, 2022 | 958.00M |
| June 30, 2022 | 848.00M |
| March 31, 2022 | 758.00M |
| Date | Value |
|---|---|
| December 31, 2021 | 567.00M |
| September 30, 2021 | 444.99M |
| June 30, 2021 | 325.53M |
| March 31, 2021 | 241.15M |
| December 31, 2020 | 188.27M |
| September 30, 2020 | 135.13M |
| June 30, 2020 | 114.77M |
| March 31, 2020 | 106.63M |
| December 31, 2019 | 109.77M |
| September 30, 2019 | 121.94M |
| June 30, 2019 | 112.29M |
| March 31, 2019 | 105.19M |
| December 31, 2018 | 94.25M |
| September 30, 2018 | 72.13M |
| June 30, 2018 | 70.34M |
| March 31, 2018 | 48.95M |
| December 31, 2017 | 32.64M |
| September 30, 2017 | 16.73M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vaxcyte, Inc. | 132.67M |
| Revolution Medicines, Inc. | 330.91M |
| Sarepta Therapeutics, Inc. | 436.74M |
| Twist Bioscience Corp. | 290.29M |
| BioNTech SE | 833.57M |